Vice President – New Ventures
RTW Investments
Vice President – New Ventures
RTW Investments
Lifecycle-focused life sciences investor
Vice President – New Ventures, Asset Selection
RTW Investments
RTW Investments, LP (“RTW”) is a global, full life-cycle investment and innovation firm dedicated to solving the most challenging, unmet patient needs. We are focused on company building and identifying transformational and disruptive innovations across the biopharmaceutical and medical technologies sectors. Our investment philosophy combines a deep understanding of disease, biology, medicine, and technology with a comprehensive view of commercial opportunities and challenges. Our talented team brings hands-on expertise in targeted areas of innovation, dedicated to the diligent exploration and support of emerging breakthroughs in both industry and academia.
Our mission is simple: we power breakthrough therapies that transform the lives of millions.
RTW Investments – Recent Press
Role Overview
The Vice President will work with the Managing Director and New Ventures team to identify and evaluation opportunities for company creation. The Vice President will be responsible for developing investment theses for drug acquisition targets within given therapeutic area(s).
This position is full-time and reports to the Managing Director, New Ventures.
Key Responsibilities
Qualifications and Skills
The duties and responsibilities described are not a comprehensive list and additional tasks may be assigned to the employee from time to time.
Compensation & Benefits
The total compensation for this role includes a base salary, competitive bonus structure, and comprehensive benefits. The target annual cash compensation range is $425,000+, though will be determined by a variety of factors including prior experience, relevant expertise, and the scope of responsibilities assigned.
Lifecycle-focused life sciences investor
RTW Investments, LP is a global life sciences investment firm that guides assets through the full investment lifecycle, from early research and company creation to venture and public-market investing. Its approach centers on science-led analysis to identify biopharmaceutical and medical technology assets with high growth potential and then allocates capital across stages, earning fees and performance-based rewards. The firm differentiates itself by combining early-stage company creation with later-stage and public-market investing, enabling long-term partnerships and deeper involvement across the company’s growth, with a global footprint in New York, London, and Shanghai. Its goal is to bring transformative therapies and medical technologies to commercialization, improving patient outcomes while delivering returns for its funds.
Explore more opportunities at RTW Investments